We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
(+16%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
5.36%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$84.4M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$81.5M |
| 3 |
Valaris
VAL
|
+$24.1M |
| 4 |
CAI
CAI International, Inc.
CAI
|
+$12.6M |
| 5 |
STMP
Stamps.com, Inc.
STMP
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22.9M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$19.4M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
+$19M |
| 4 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$16.1M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.4% |
| 2 | Technology | 6.32% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 4.27% |
| 5 | Communication Services | 2.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Arista Networks
ANET
$241B
| – | – |
-24,240
| Closed | -$549K |
|
1677
Angi Inc
ANGI
$184M
| – | – |
-10,544
| Closed | -$1.43M |
|
|
ANSS
1678
DELISTED
Ansys
ANSS
| – | – |
-2,737
| Closed | -$950K |
|
1679
Annovis Bio
ANVS
$79.1M
| – | – |
-7,770
| Closed | -$665K |
|
1680
CALL
Aon
AON
$75.6B
| – | – |
-7,000
| Closed | -$1.67M |
|
|
1681
Aon
AON
$75.6B
| – | – |
-5,332
| Closed | -$1.27M |
|
1682
APA Corp
APA
$14.2B
| – | – |
-138,188
| Closed | -$2.99M |
|
1683
APi Group
APG
$18.2B
| – | – |
-40,254
| Closed | -$561K |
|
|
APLS
1684
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-4,434
| Closed | -$280K |
|
1685
Alexandria Real Estate Equities
ARE
$8.29B
| – | – |
-5,025
| Closed | -$920K |
|
|
ARR
1686
Armour Residential REIT
ARR
$2.33B
| – | – |
-6,960
| Closed | -$397K |
|
1687
Arrowhead Research
ARWR
$12.5B
| – | – |
-5,675
| Closed | -$470K |
|
1688
Arrow Electronics
ARW
$10.4B
| – | – |
-4,302
| Closed | -$490K |
|
|
EFOR
1689
Everforth Inc
EFOR
$1.36B
| – | – |
-4,672
| Closed | -$453K |
|
1690
Ashland
ASH
$3.45B
| – | – |
-2,858
| Closed | -$250K |
|
1691
AerSale
ASLE
$268M
| – | – |
-30,170
| Closed | -$376K |
|
1692
ASML
ASML
$672B
| – | – |
-1,635
| Closed | -$1.13M |
|
1693
Amtech Systems
ASYS
$269M
| – | – |
-29,977
| Closed | -$289K |
|
1694
Atmos Energy
ATO
$28.3B
| – | – |
-2,337
| Closed | -$225K |
|
1695
Atara Biotherapeutics
ATRA
$76.2M
| – | – |
-3,191
| Closed | -$1.24M |
|
1696
Avnet
AVT
$7.93B
| – | – |
-7,188
| Closed | -$288K |
|
1697
Avery Dennison
AVY
$13.5B
| – | – |
-2,487
| Closed | -$523K |
|
1698
American Express
AXP
$228B
| – | – |
-4,523
| Closed | -$756K |
|
1699
Axalta
AXTA
$8.06B
| – | – |
-11,626
| Closed | -$348K |
|
1700
CALL
AstraZeneca
AZN
$251B
| – | – |
-37,500
| Closed | -$4.49M |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.
- Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
- Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
- Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
- Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
- Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
- Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
- Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.
Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.